Grand Canyon Education, Inc. (LOPE) is a Phoenix-based education services company that provides technology, academic, counseling, and marketing support to Grand Canyon University and other partner institutions. It is a stock, not an exchange-traded fund.
Three current, individually attributable analyst price targets were reviewed. BMO Capital (Jeffrey Silber) holds a Buy rating with a $182 target, lowered from $185 in October 2026. Barrington Research (Alexander Paris) reiterates Outperform with a $200 target, trimmed from $230 earlier in 2026 after the company slightly reduced fiscal 2026 guidance. Truist Financial (Jasper Bibb) maintains Buy with a $200 target. The arithmetic mean of these three targets is $194, which rounds to the $190 central target used here. The low-to-high range is approximately $182 to $200, a relatively tight spread that signals broad agreement on direction but some disagreement on magnitude.
Ratings skew bullish, with Buy or Outperform designations and no current Sell or Hold ratings among these three firms. The consistent theme is that LOPE is a high-quality, asset-light education-services business with durable enrollment trends. The $18 gap between the lowest and highest target largely reflects different assumptions about revenue growth and the resolution of regulatory uncertainty, not fundamentally opposing views on the company.
LOPE closed near $150.67 in early November 2026. Reaching $190 implies upside of roughly 26%, a substantial move for a stock that has already pulled back well below its 52-week high. The path would likely require several quarters of sustained enrollment growth, stabilization of revenue growth toward the mid-single digits, and continued share repurchases that reduce the share count and support EPS (earnings per share).
Fundamentals remain modest but positive. Full-year 2026 revenue is projected around $1.17 billion, up roughly 5.6%, with EPS near $10.21 and further growth expected in 2027. The forward P/E (price-to-earnings) ratio sits around 14, below the broader market, meaning a portion of any move toward $190 could come from modest multiple expansion if investor confidence in the regulatory outlook improves.
LOPE trades roughly 12% above its 52-week low near $134, a durable support zone that has held through recent volatility. The stock has also declined meaningfully from its 52-week high, leaving overhead supply to work through. Resistance is likely to be encountered in the mid-$150s to low-$160s, an area near prior price congestion and the 200-day moving average, before the stock could build a base toward the $190 level. A sustained break back above that congestion zone would be an important structural signal, while a loss of the $134 support would suggest deeper downside risk.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms vary. Investors weighing the $190 objective should monitor quarterly enrollment and revenue growth, any updates on the government probe and the CFO's status, full-year 2027 guidance, and the pace of share repurchases. Changes in analyst estimates or targets, particularly any further guidance reductions, would also be key signals. Macroeconomic factors such as interest rates and federal education policy are less direct but still relevant to demand and valuation.
For traders who want a more systematic way to track changing conditions, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. The tool is designed to help investors discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening alone. As you follow LOPE's path toward its target, consider using AI Daily Buy/Sell Signals to stay current on shifting momentum.
The $190 central target, derived from three analyst price targets averaging $194, sits about 26% above the recent price near $151. Reaching it would require enrollment and revenue growth to reaccelerate, continued share repurchases, and some easing of the regulatory overhang that has weighed on the stock. The strongest supports are durable online and hybrid enrollment, a low valuation, and an asset-light, cash-generative model. The principal obstacles are the ongoing government probe, the CFO's administrative leave, and slowing revenue growth that has already prompted two firms to lower their targets. With a tight $182-to-$200 analyst range and no bearish ratings, the outlook is constructive but far from assured. Investors should monitor enrollment trends, guidance, and any regulatory developments rather than treat the $190 figure as a guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, LOPE has been closely correlated with STRA. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if LOPE jumps, then STRA could also see price increases.
| Ticker / NAME | Correlation To LOPE | 1D Price Change % | ||
|---|---|---|---|---|
| LOPE | 100% | +0.29% | ||
| STRA - LOPE | 79% Closely correlated | +3.10% | ||
| PRDO - LOPE | 75% Closely correlated | +5.21% | ||
| CVSA - LOPE | 65% Loosely correlated | +2.21% | ||
| LAUR - LOPE | 47% Loosely correlated | +1.16% | ||
| CTAS - LOPE | 45% Loosely correlated | +0.95% | ||
More | ||||
| Ticker / NAME | Correlation To LOPE | 1D Price Change % |
|---|---|---|
| LOPE | 100% | +0.29% |
| LOPE (3 stocks) | 97% Closely correlated | +0.18% |
| Other Consumer Specialties (43 stocks) | 15% Poorly correlated | +0.15% |
| Consumer Durables (204 stocks) | -5% Poorly correlated | +0.11% |